<DOC>
	<DOCNO>NCT00557349</DOCNO>
	<brief_summary>This research determine medication , Zegerid ( Omeprazole/Sodium Bicarbonate ) Pepcid AC ( Famotidine ) , work best reduce chance patient get ulcer gastric bypass surgery .</brief_summary>
	<brief_title>Ulcer Prevention Study Post Gastric Bypass Patients</brief_title>
	<detailed_description>The purpose research evaluate information control gastric acid post gastric bypass surgery patient . Goal determine medication best reduces incidence anastomotic ulcer post-operatively .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Omeprazole , sodium bicarbonate drug combination</mesh_term>
	<criteria>Subject age â‰¥ 18 year Patient meet criterion laparoscopic gastric bypass surgery Females : Patient willing take urine pregnancy test Subject allergic omeprazole famotidine Patient receive antifungal ( i.e . ketoconazole itraconazole ) Hepatic insufficiency History Crohns disease History ZollingerEllison disease Patient receive investigational drug within 30 day enrollment Patient currently enrol another research project Females Only : Pregnancy plan become pregnant next 14 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>gastric bypass surgery</keyword>
	<keyword>anastomosis , Roux-en-Y</keyword>
	<keyword>Complication , Postoperative</keyword>
</DOC>